BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 22762741)

  • 1. Innate and lymphocytic response of birch-allergic patients before and after sublingual immunotherapy.
    Guida G; Boita M; Scirelli T; Bommarito L; Heffler E; Badiu I; Bellone G; Mietta S; Mistrello G; Rolla G
    Allergy Asthma Proc; 2012; 33(5):411-5. PubMed ID: 22762741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation.
    Möbs C; Slotosch C; Löffler H; Jakob T; Hertl M; Pfützner W
    J Immunol; 2010 Feb; 184(4):2194-203. PubMed ID: 20048125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergen-specific CD4+ T cell responses in peripheral blood do not predict the early onset of clinical efficacy during grass pollen sublingual immunotherapy.
    Bonvalet M; Moussu H; Wambre E; Ricarte C; Horiot S; Rimaniol AC; Kwok WW; Horak F; de Beaumont O; Baron-Bodo V; Moingeon P
    Clin Exp Allergy; 2012 Dec; 42(12):1745-55. PubMed ID: 23181790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies.
    Möbs C; Ipsen H; Mayer L; Slotosch C; Petersen A; Würtzen PA; Hertl M; Pfützner W
    J Allergy Clin Immunol; 2012 Nov; 130(5):1108-1116.e6. PubMed ID: 23021882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune regulation by CD4+CD25+ T cells and interleukin-10 in birch pollen-allergic patients and non-allergic controls.
    Thunberg S; Akdis M; Akdis CA; Grönneberg R; Malmström V; Trollmo C; van Hage M; Gafvelin G
    Clin Exp Allergy; 2007 Aug; 37(8):1127-36. PubMed ID: 17651141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and immunological correlates of pre-co-seasonal sublingual immunotherapy with birch monomeric allergoid in patients with allergic rhinoconjunctivitis.
    Burastero SE; Mistrello G; Paolucci C; Breda D; Roncarolo D; Zanotta S; Falagiani P
    Int J Immunopathol Pharmacol; 2009; 22(2):343-52. PubMed ID: 19505388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC.
    Savolainen J; Jacobsen L; Valovirta E
    Allergy; 2006 Oct; 61(10):1184-90. PubMed ID: 16942566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of CD154+ T cells following ex vivo birch allergen stimulation defines a close relationship between T cell subsets in healthy volunteers.
    Smith KA; Gray NJ; Cheek E; Saleh F; Lavender J; Frew AJ; Kern F; Tarzi MD
    BMC Immunol; 2013 Mar; 14():14. PubMed ID: 23521868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allergen-induced in vitro expression of IL-18, SLAM and GATA-3 mRNA in PBMC during sublingual immunotherapy.
    Savolainen J; Nieminen K; Laaksonen K; Laiho T; Jacobsen L; Lahesmaa R; Terho EO; Valovirta E
    Allergy; 2007 Aug; 62(8):949-53. PubMed ID: 17620074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oralair Birch, a recombinant major birch pollen allergen tablet for sublingual immunotherapy of allergic rhinitis caused by birch pollen.
    Larenas-Linnemann D
    Curr Opin Investig Drugs; 2010 May; 11(5):586-96. PubMed ID: 20419605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective suppression of Th2 cytokines by CD4CD25 regulatory T cells in birch allergics during birch pollen season.
    Grindebacke H; Wing K; Andersson AC; Suri-Payer E; Rak S; Rudin A
    Clin Exp Allergy; 2004 Sep; 34(9):1364-72. PubMed ID: 15347368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-year follow-up study of allergen-induced in vitro cytokine and signalling lymphocytic activation molecule mRNA responses in peripheral blood mononuclear cells of allergic rhinitis patients undergoing specific immunotherapy.
    Nieminen K; Laaksonen K; Savolainen J
    Int Arch Allergy Immunol; 2009; 150(4):370-6. PubMed ID: 19571569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of allergen-specific immunotherapy on functions of helper and regulatory T cells in patients with seasonal allergic rhinitis.
    Kirmaz C; Ozenturk Kirgiz O; Bayrak P; Yilmaz O; Vatansever S; Ozbilgin K; Onur E; Celik O; Sogut A; Ay G; Yuksel H
    Eur Cytokine Netw; 2011 Mar; 22(1):15-23. PubMed ID: 21421451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of sublingual immunotherapy with grass monomeric allergoid on allergen-specific T-cell proliferation and interleukin 10 production.
    Burastero SE; Mistrello G; Falagiani P; Paolucci C; Breda D; Roncarolo D; Zanotta S; Monasterolo G; Rossi RE
    Ann Allergy Asthma Immunol; 2008 Apr; 100(4):343-50. PubMed ID: 18450120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation.
    Bohle B; Kinaciyan T; Gerstmayr M; Radakovics A; Jahn-Schmid B; Ebner C
    J Allergy Clin Immunol; 2007 Sep; 120(3):707-13. PubMed ID: 17681368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired maturation of monocyte-derived dendritic cells from birch allergic individuals in association with birch-specific immune responses.
    Casas R; Skarsvik S; Lindström A; Zetterström O; Duchén K
    Scand J Immunol; 2007 Nov; 66(5):591-8. PubMed ID: 17868259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sublingual immunotherapy: an update on immunologic and functional effects.
    Ciprandi G; Fenoglio D; Cirillo I; Tosca MA; La Rosa M; Licari A; Marseglia A; Barberi S; Marseglia GL
    Allergy Asthma Proc; 2007; 28(1):40-3. PubMed ID: 17390756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.
    Cosmi L; Santarlasci V; Angeli R; Liotta F; Maggi L; Frosali F; Rossi O; Falagiani P; Riva G; Romagnani S; Annunziato F; Maggi E
    Clin Exp Allergy; 2006 Mar; 36(3):261-72. PubMed ID: 16499636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The major birch pollen allergen Bet v 1 induces different responses in dendritic cells of birch pollen allergic and healthy individuals.
    Smole U; Radauer C; Lengger N; Svoboda M; Rigby N; Bublin M; Gaier S; Hoffmann-Sommergruber K; Jensen-Jarolim E; Mechtcheriakova D; Breiteneder H
    PLoS One; 2015; 10(1):e0117904. PubMed ID: 25635684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential T-cell responses and allergen uptake after exposure of dendritic cells to the birch pollen allergens Bet v 1.0101, Bet v 1.0401 and Bet v 1.1001.
    Smole U; Balazs N; Hoffmann-Sommergruber K; Radauer C; Hafner C; Wallner M; Ferreira F; Grössinger R; de Jong EC; Wagner S; Breiteneder H
    Immunobiology; 2010 Nov; 215(11):903-9. PubMed ID: 20005001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.